Duke Center for Brain and Spine Metastasis
@dukemets.bsky.social
At Duke, some of the world's top experts are taking the lead on a new and distinctive approach to address brain and spine metastases.
#MetsGetsAwareness | #MedSky | #OncSky | #AcademicSky
brainspinemetastasis.org
#MetsGetsAwareness | #MedSky | #OncSky | #AcademicSky
brainspinemetastasis.org
Joel Graybeal was diagnosed with #ProstateCancer in July 2022 and learned that it had already metastasized. In an interview with People, Joel and his wife share how they refuse to let cancer stop them from living the life of their dreams.
people.com/prostate-can...
people.com/prostate-can...
N.C. Couple Makes 'Every Minute Count' After Metastatic Prostate Cancer Diagnosis: 'So Grateful for Any Time I Get with This Man'
Joel and Caroline Graybeal became a powerful team in the face of his health news – and they're making the most of their 'blessings' with travel and time together. "You can't give cancer the power to t...
people.com
July 16, 2025 at 3:47 PM
Joel Graybeal was diagnosed with #ProstateCancer in July 2022 and learned that it had already metastasized. In an interview with People, Joel and his wife share how they refuse to let cancer stop them from living the life of their dreams.
people.com/prostate-can...
people.com/prostate-can...
Like the brain, almost all cancers can spread to the bone but some are more likely than others. Breast, lung, prostate, kidney, melanoma, ovarian, and thyroid cancers are the most common. The spine is the most common site for bone metastases.
June 27, 2025 at 2:40 PM
Like the brain, almost all cancers can spread to the bone but some are more likely than others. Breast, lung, prostate, kidney, melanoma, ovarian, and thyroid cancers are the most common. The spine is the most common site for bone metastases.
It takes a village to care for patients. Visit brainspinemetastasis.org to find patient resources and our partner organizations.
June 26, 2025 at 1:27 PM
It takes a village to care for patients. Visit brainspinemetastasis.org to find patient resources and our partner organizations.
Thank you to Rep. Valerie Foushee (NC-04) for continuing to support brain and spine metastasis awareness. On Monday, Rep. Foushee reintroduced a resolution naming June Brain and Spine Metastasis Awareness Month.
Read more: neurosurgery.duke.edu/news/foushee...
Read more: neurosurgery.duke.edu/news/foushee...
Foushee reintroduces Brain Spine Metastasis Awareness Month resolution
Rep. Valerie Foushee (NC-04) Monday reintroduced a resolution designating June as Brain and Spine Metastasis Awareness Month.
neurosurgery.duke.edu
June 24, 2025 at 5:41 PM
Thank you to Rep. Valerie Foushee (NC-04) for continuing to support brain and spine metastasis awareness. On Monday, Rep. Foushee reintroduced a resolution naming June Brain and Spine Metastasis Awareness Month.
Read more: neurosurgery.duke.edu/news/foushee...
Read more: neurosurgery.duke.edu/news/foushee...
Until about 10 years ago, patients with brain and spine metastases weren't eligible to participate in clinical trials. Today, we have trials designed specifically for these patients.
Learn more about active trials here: neurosurgery.duke.edu/mets-resources
Learn more about active trials here: neurosurgery.duke.edu/mets-resources
June 24, 2025 at 4:25 PM
Until about 10 years ago, patients with brain and spine metastases weren't eligible to participate in clinical trials. Today, we have trials designed specifically for these patients.
Learn more about active trials here: neurosurgery.duke.edu/mets-resources
Learn more about active trials here: neurosurgery.duke.edu/mets-resources
About 15% of people with kidney cancer will develop brain metastases.
June 23, 2025 at 1:22 PM
About 15% of people with kidney cancer will develop brain metastases.
Everything changed for Brian FitzGerald in an instant. After spending the summer looking for answers, one last scan kicked off a whirlwind of surgery and treatments for melanoma that had metastasized to his brain.
Read his story here: neurosurgery.duke.edu/news/south-c...
Read his story here: neurosurgery.duke.edu/news/south-c...
June 20, 2025 at 12:53 PM
Everything changed for Brian FitzGerald in an instant. After spending the summer looking for answers, one last scan kicked off a whirlwind of surgery and treatments for melanoma that had metastasized to his brain.
Read his story here: neurosurgery.duke.edu/news/south-c...
Read his story here: neurosurgery.duke.edu/news/south-c...
It's important for caregivers to take care of themselves, too. That means practicing self-care, but also recognizing burnout and when to ask for help.
June 19, 2025 at 6:28 PM
It's important for caregivers to take care of themselves, too. That means practicing self-care, but also recognizing burnout and when to ask for help.
Duke's April Salama, MD, and Lucy Boyce Kennedy, MD, of Cleveland Clinic published a review looking at how to choose therapies to treat metastatic melanoma.
Read the review here: link.springer.com/article/10.1...
Read the review here: link.springer.com/article/10.1...
June 18, 2025 at 1:21 PM
Duke's April Salama, MD, and Lucy Boyce Kennedy, MD, of Cleveland Clinic published a review looking at how to choose therapies to treat metastatic melanoma.
Read the review here: link.springer.com/article/10.1...
Read the review here: link.springer.com/article/10.1...
SRS (stereotactic radiosurgery) uses high radiation doses in precisely targeted areas to treat tumors, especially in delicate places like the brain.
SRS minimizes damage to nearby healthy tissue compared to whole brain radiation. Learn more: www.dukehealth.org/treatments/s...
Source: Duke Health
SRS minimizes damage to nearby healthy tissue compared to whole brain radiation. Learn more: www.dukehealth.org/treatments/s...
Source: Duke Health
June 17, 2025 at 3:41 PM
SRS (stereotactic radiosurgery) uses high radiation doses in precisely targeted areas to treat tumors, especially in delicate places like the brain.
SRS minimizes damage to nearby healthy tissue compared to whole brain radiation. Learn more: www.dukehealth.org/treatments/s...
Source: Duke Health
SRS minimizes damage to nearby healthy tissue compared to whole brain radiation. Learn more: www.dukehealth.org/treatments/s...
Source: Duke Health
Brain metastases are one of the most common complications of melanoma. More than 60% of stage IV melanoma patients will develop brain metastases.
Source: AIM at Melanoma
Source: AIM at Melanoma
June 16, 2025 at 2:29 PM
Brain metastases are one of the most common complications of melanoma. More than 60% of stage IV melanoma patients will develop brain metastases.
Source: AIM at Melanoma
Source: AIM at Melanoma
Cancer support services are about making sure patients are cared for as a whole person. At Duke, services include supportive counseling, child life specialists, nutrition & exercise consultations, physical & occupational therapy, & palliative care. Learn more:
www.dukehealth.org/locations/du...
www.dukehealth.org/locations/du...
June 12, 2025 at 3:18 PM
Cancer support services are about making sure patients are cared for as a whole person. At Duke, services include supportive counseling, child life specialists, nutrition & exercise consultations, physical & occupational therapy, & palliative care. Learn more:
www.dukehealth.org/locations/du...
www.dukehealth.org/locations/du...
Researchers at Duke have found that breast cancer can enter the lining of the brain (leptomeninges) through bone marrow and emissary veins. Read more here:
neurosurgery.duke.edu/news/duke-re...
#AcademicSky #OncSky #MedSky
neurosurgery.duke.edu/news/duke-re...
#AcademicSky #OncSky #MedSky
June 11, 2025 at 11:48 AM
Researchers at Duke have found that breast cancer can enter the lining of the brain (leptomeninges) through bone marrow and emissary veins. Read more here:
neurosurgery.duke.edu/news/duke-re...
#AcademicSky #OncSky #MedSky
neurosurgery.duke.edu/news/duke-re...
#AcademicSky #OncSky #MedSky
Antibody-drug conjugates (ADCs) combine a monoclonal antibody and chemotherapy with a linking protein. The antibody will only bind to one substance which targets the chemotherapy to specific cancer cells, making healthy cell less likely to be harmed.
June 10, 2025 at 4:56 PM
Antibody-drug conjugates (ADCs) combine a monoclonal antibody and chemotherapy with a linking protein. The antibody will only bind to one substance which targets the chemotherapy to specific cancer cells, making healthy cell less likely to be harmed.
More than 60% of patients with advanced prostate cancer will eventually develop bone metastases. The spine is one of the most common places for bone metastasis.
June 9, 2025 at 5:01 PM
More than 60% of patients with advanced prostate cancer will eventually develop bone metastases. The spine is one of the most common places for bone metastasis.
10-15% of people with stage IV breast cancer have brain metastases.
June 9, 2025 at 5:01 PM
10-15% of people with stage IV breast cancer have brain metastases.
Metastatic brain tumors are different than primary brain tumors. Not only are they more common, they're not actually brain cancer. The cancer is still the primary cancer - lung, breast, or others - but that cancer is now in the brain.
June 6, 2025 at 1:03 PM
Metastatic brain tumors are different than primary brain tumors. Not only are they more common, they're not actually brain cancer. The cancer is still the primary cancer - lung, breast, or others - but that cancer is now in the brain.
Palliative care is about providing relief and preventing suffering at any age or stage of illness. Palliative care experts partner with patients, their families, and their medical teams to meet your personalized goals.
June 5, 2025 at 1:18 PM
Palliative care is about providing relief and preventing suffering at any age or stage of illness. Palliative care experts partner with patients, their families, and their medical teams to meet your personalized goals.
A recent study by DCBSM researchers found a nearly two-fold increase in the risk of radiation necrosis among patients with brain metastases receiving immunotherapies within four weeks of radiosurgery.
Learn more: neurosurgery.duke.edu/news/therapy...
#OncSky #MedSky #AcademicSky
Learn more: neurosurgery.duke.edu/news/therapy...
#OncSky #MedSky #AcademicSky
June 4, 2025 at 12:57 PM
A recent study by DCBSM researchers found a nearly two-fold increase in the risk of radiation necrosis among patients with brain metastases receiving immunotherapies within four weeks of radiosurgery.
Learn more: neurosurgery.duke.edu/news/therapy...
#OncSky #MedSky #AcademicSky
Learn more: neurosurgery.duke.edu/news/therapy...
#OncSky #MedSky #AcademicSky
LITT (laser interstitial thermal therapy) uses a laser to destroy unhealthy brain tissue, including new & recurrent brain tumors & radiation necrosis.
LITT is minimally invasive - the opening in the scalp is only about as big as a pencil eraser.
Learn more: www.dukehealth.org/treatments/n...
LITT is minimally invasive - the opening in the scalp is only about as big as a pencil eraser.
Learn more: www.dukehealth.org/treatments/n...
June 3, 2025 at 3:26 PM
LITT (laser interstitial thermal therapy) uses a laser to destroy unhealthy brain tissue, including new & recurrent brain tumors & radiation necrosis.
LITT is minimally invasive - the opening in the scalp is only about as big as a pencil eraser.
Learn more: www.dukehealth.org/treatments/n...
LITT is minimally invasive - the opening in the scalp is only about as big as a pencil eraser.
Learn more: www.dukehealth.org/treatments/n...
New research from members of the DCBSM & Duke Radiation Oncology graduate students highlights using artificial intelligence to differentiate between local recurrence & radiation necrosis in patients with brain metastasis.
#AcademicSky #MedSky #OncSky
www.dukecancerinstitute.org/blogs/new-ai...
#AcademicSky #MedSky #OncSky
www.dukecancerinstitute.org/blogs/new-ai...
New AI Methods Advance Diagnosis After Brain Metastasis Treatment
New research from a team of experts at Duke University School of Medicine highlights the use of artificial intelligence (AI) and computational methods to differentiate between local recurrence and rad...
www.dukecancerinstitute.org
May 29, 2025 at 2:10 PM
New research from members of the DCBSM & Duke Radiation Oncology graduate students highlights using artificial intelligence to differentiate between local recurrence & radiation necrosis in patients with brain metastasis.
#AcademicSky #MedSky #OncSky
www.dukecancerinstitute.org/blogs/new-ai...
#AcademicSky #MedSky #OncSky
www.dukecancerinstitute.org/blogs/new-ai...
We're excited to virtually welcome Melanie Hayden Gephart to Duke on May 22! Dr. Hayden Gephart is a brain tumor neurosurgeon at Stanford University.
Find more information and the Zoom link here:
calendar.duke.edu/show?fq=id%3...
CME is available for this event.
Find more information and the Zoom link here:
calendar.duke.edu/show?fq=id%3...
CME is available for this event.
May 8, 2025 at 1:58 PM
We're excited to virtually welcome Melanie Hayden Gephart to Duke on May 22! Dr. Hayden Gephart is a brain tumor neurosurgeon at Stanford University.
Find more information and the Zoom link here:
calendar.duke.edu/show?fq=id%3...
CME is available for this event.
Find more information and the Zoom link here:
calendar.duke.edu/show?fq=id%3...
CME is available for this event.
Reductions in cancer death rates translates to more than 4.1 million cancer deaths avoided in the U.S. between 1991 and 2021. The decline is due to advancements in treatments and early detection thanks to cancer research.
Source: @theaacr.bsky.social #UnitedByCancerResearch #NCRM25
Source: @theaacr.bsky.social #UnitedByCancerResearch #NCRM25
May 5, 2025 at 6:03 PM
Reductions in cancer death rates translates to more than 4.1 million cancer deaths avoided in the U.S. between 1991 and 2021. The decline is due to advancements in treatments and early detection thanks to cancer research.
Source: @theaacr.bsky.social #UnitedByCancerResearch #NCRM25
Source: @theaacr.bsky.social #UnitedByCancerResearch #NCRM25